Catalyst Biosciences Inc (NASDAQ: CBIO) stock closed at $22.51 on 1/12/24 after a major decline of -14.6%. However, this decline was accompanied by unusually low trading volume at 58% of normal. The stock has been exceptionally strong relative to the market over the last nine months but has declined -6.8% during the last week.
Current PriceTarget Research Rating
With future capital returns forecasted to be below the cost of capital, CBIO is expected to be a major Value Eraser.
Catalyst Biosciences is currently unrated.
Rating Review
The stock is currently unrated.
Be the first to comment